Diligence memo · auto-generated · as of July 2, 2026
Lam Pharmaceutical Corp
Lam Pharmaceutical Corp looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Lam Pharmaceutical Corp operates in Pharmaceuticals, based in TORONTO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Lam Pharmaceutical Corp has raised $172K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $172K on 2013-08-01.
Most recent recorded round closed around 2013-08-01.
Valuation (modeled)modeled
Provath models Lam Pharmaceutical Corp at approximately $8.1M (range $96K–$92M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.72× the median modeled value of Pre-Seed Pharmaceuticals companies in 2013–2015 (87 peers) — value vs value, same stage and era. Within the normal band (72% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 12.9 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 3% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 14% of those peers.
Closest niche peers: IPM Safety Services, Inc., Scioderm, LLC, Chondrial Therapeutics, LLC, OnCore Biopharma, Inc., VR1 Corp.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.